Cite
MLA Citation
Kristian Reich et al.. “Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial.” Lancet, vol. 394, no. 10201, 2019, pp. 831–839. http://access.bl.uk/ark:/81055/vdc_100091273162.0x00004d